9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma

Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma

Estimated reading time: < 1 min

Condition: Malignant Pleural Mesothelioma

Estimated Enrollment: 68

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: response rate,  progression free survival (PFS),  overall survival (OS), estimation of treatment related toxicity

Interventions: ,

Phase:

Study Type: Observational

Study Design: Observational Model: Cohort, Time Perspective: Prospective, ,

Primary Completion Date: June 2016

Completion Date: December 2016

Last  Posted Date: January 3, 2018

Location: Ain Shams University Hospitals, Cairo, Abbasia, Egypt

Website Link: https://ClinicalTrials.gov/show/NCT02269878

Was this article helpful?
Dislike 0